This article is for premium subscribers. Please sign up here for a tax-deductible subscription.
If you're a premium subscriber, sign in below.
A legislative proposal for importing wholesale prescription drugs from Canada has died -- for the second time.
House Bill 4147 was effectively killed by House health care leaders who did not put it on the committee agenda.
During the 2020 State of the Union address, President Donald Trump zeroed in on prescription drug prices, arguing that his administration is “taking on the big pharmaceutical companies.”
Polls say health care is consistently at the top of voters’ minds in this election cycle. And President Donald Trump clearly wants to own the issue, often talking about the “wins” stemming from his administration’s policies.
This article is for premium subscribers. Please sign up here for a tax-deductible subscription.
If you're a premium subscriber, sign in below.
On Jan. 1, a host of new laws took effect in Oregon on topics that include health care and industry.
In a historic shift, the federal government Wednesday proposed allowing states to import drugs from Canada. Officials said they believe it can be done safely and save significant money for Americans.
This article is for premium subscribers. Please sign up here for a tax-deductible subscription.
If you're a premium subscriber, sign in below.
The Oregon Legislature ended its session on Sunday after a marathon weekend in which it passed several health care bills, including one that went down to the wire.
This article is for premium subscribers. Please sign up here for a tax-deductible subscription.
If you're a premium subscriber, sign in below.
Sweeping bipartisan majorities last week passed into law House Bill 4005,setting up a system for the state to demand more transparency from
Medicare enrollees, who have watched their out-of-pocket spending on prescription drugs climb in recent years, might be in for a break.
Access to powerful new cholesterol-lowering drugs is so tightly controlled and patients’ out-of-pocket costs are so high that fewer than a third of people whose doctors prescribe the drugs get them, a new study found.
